75 related articles for article (PubMed ID: 24754711)
21. Synthesis and evaluation of 1-[2-(4-[(11)C]methoxyphenyl)phenyl]piperazine for imaging of the serotonin 5-HT7 receptor in the rat brain.
Shimoda Y; Yui J; Xie L; Fujinaga M; Yamasaki T; Ogawa M; Nengaki N; Kumata K; Hatori A; Kawamura K; Zhang MR
Bioorg Med Chem; 2013 Sep; 21(17):5316-22. PubMed ID: 23830697
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and evaluation of 18F-labeled dopamine D3 receptor ligands as potential PET imaging agents.
Hocke C; Prante O; Löber S; Hübner H; Gmeiner P; Kuwert T
Bioorg Med Chem Lett; 2005 Nov; 15(21):4819-23. PubMed ID: 16139501
[TBL] [Abstract][Full Text] [Related]
23. Discovery of N1-(6-chloroimidazo[2,1-b][1,3]thiazole-5-sulfonyl)tryptamine as a potent, selective, and orally active 5-HT(6) receptor agonist.
Cole DC; Stock JR; Lennox WJ; Bernotas RC; Ellingboe JW; Boikess S; Coupet J; Smith DL; Leung L; Zhang GM; Feng X; Kelly MF; Galante R; Huang P; Dawson LA; Marquis K; Rosenzweig-Lipson S; Beyer CE; Schechter LE
J Med Chem; 2007 Nov; 50(23):5535-8. PubMed ID: 17948978
[TBL] [Abstract][Full Text] [Related]
24. [18F]DPA-714, [18F]PBR111 and [18F]FEDAA1106-selective radioligands for imaging TSPO 18 kDa with PET: automated radiosynthesis on a TRACERLAb FX-FN synthesizer and quality controls.
Kuhnast B; Damont A; Hinnen F; Catarina T; Demphel S; Le Helleix S; Coulon C; Goutal S; Gervais P; Dollé F
Appl Radiat Isot; 2012 Mar; 70(3):489-97. PubMed ID: 22104496
[TBL] [Abstract][Full Text] [Related]
25. Fluorinated molecules in the diagnosis and treatment of neurodegenerative diseases.
Gaye B; Adejare A
Future Med Chem; 2009 Aug; 1(5):821-33. PubMed ID: 21426082
[TBL] [Abstract][Full Text] [Related]
26. Structure-selectivity investigations of D2-like receptor ligands by CoMFA and CoMSIA guiding the discovery of D3 selective PET radioligands.
Salama I; Hocke C; Utz W; Prante O; Boeckler F; Hübner H; Kuwert T; Gmeiner P
J Med Chem; 2007 Feb; 50(3):489-500. PubMed ID: 17266201
[TBL] [Abstract][Full Text] [Related]
27. Fluorine-18 radiolabeling and radiopharmacological characterization of a benzodioxolylpyrimidine-based radiotracer targeting the receptor tyrosine kinase EphB4.
Mamat C; Mosch B; Neuber C; Köckerling M; Bergmann R; Pietzsch J
ChemMedChem; 2012 Nov; 7(11):1991-2003. PubMed ID: 23042640
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and preliminary evaluation of [(18)F]-fluoro-(2S)-Exaprolol for imaging cerebral beta-adrenergic receptors with PET.
Stephenson KA; van Oosten EM; Wilson AA; Meyer JH; Houle S; Vasdev N
Neurochem Int; 2008 Nov; 53(5):173-9. PubMed ID: 18675864
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and biological evaluation of carbon-11- and fluorine-18-labeled 2-oxoquinoline derivatives for type 2 cannabinoid receptor positron emission tomography imaging.
Evens N; Muccioli GG; Houbrechts N; Lambert DM; Verbruggen AM; Van Laere K; Bormans GM
Nucl Med Biol; 2009 May; 36(4):455-65. PubMed ID: 19423014
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, evaluation, and radiolabeling of new potent positive allosteric modulators of the metabotropic glutamate receptor 2 as potential tracers for positron emission tomography imaging.
Andrés JI; Alcázar J; Cid JM; De Angelis M; Iturrino L; Langlois X; Lavreysen H; Trabanco AA; Celen S; Bormans G
J Med Chem; 2012 Oct; 55(20):8685-99. PubMed ID: 22992024
[TBL] [Abstract][Full Text] [Related]
31. Docking study, synthesis, and in vitro evaluation of fluoro-MADAM derivatives as SERT ligands for PET imaging.
Mavel S; Vercouillie J; Garreau L; Raguza T; Ravna AW; Chalon S; Guilloteau D; Emond P
Bioorg Med Chem; 2008 Oct; 16(19):9050-5. PubMed ID: 18793858
[TBL] [Abstract][Full Text] [Related]
32. Development and evaluation of endothelin-A receptor (radio)ligands for positron emission tomography.
Michel K; Büther K; Law MP; Wagner S; Schober O; Hermann S; Schäfers M; Riemann B; Höltke C; Kopka K
J Med Chem; 2011 Feb; 54(4):939-48. PubMed ID: 21275367
[TBL] [Abstract][Full Text] [Related]
33. Computational approaches to the design of novel 5-HT6 R ligands.
Ivanenkov YA; Majouga AG; Veselov MS; Chufarova NV; Baranovsky SS; Filkov GI
Rev Neurosci; 2014; 25(3):451-67. PubMed ID: 24867282
[TBL] [Abstract][Full Text] [Related]
34. In vitro and in vivo evaluation of [18F]-FDEGPECO as a PET tracer for imaging the metabotropic glutamate receptor subtype 5 (mGluR5).
Wanger-Baumann CA; Mu L; Honer M; Belli S; Alf MF; Schubiger PA; Krämer SD; Ametamey SM
Neuroimage; 2011 Jun; 56(3):984-91. PubMed ID: 21406237
[TBL] [Abstract][Full Text] [Related]
35. A ¹⁸F-labeled fluorobutyl-substituted spirocyclic piperidine derivative as a selective radioligand for PET Imaging of sigma₁ receptors.
Maisonial A; Grosse Maestrup E; Fischer S; Hiller A; Scheunemann M; Wiese C; Schepmann D; Steinbach J; Deuther-Conrad W; Wünsch B; Brust P
ChemMedChem; 2011 Aug; 6(8):1401-10. PubMed ID: 21618432
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of [(11)C]metergoline as a PET radiotracer for 5HTR in nonhuman primates.
Hooker JM; Kim SW; Reibel AT; Alexoff D; Xu Y; Shea C
Bioorg Med Chem; 2010 Nov; 18(22):7739-45. PubMed ID: 20451398
[TBL] [Abstract][Full Text] [Related]
37. Development and Evaluation of Two Potential 5-HT
Tampio L'Estrade E; Xiong M; Shalgunov V; Edgar FG; Volk B; Baerentzen SL; Palner M; Erlandsson M; Ohlsson T; Knudsen GM; Herth MM
ACS Chem Neurosci; 2019 Sep; 10(9):3961-3968. PubMed ID: 30973705
[TBL] [Abstract][Full Text] [Related]
38. PET Radioligands for imaging of the PDE10A in human: current status.
Boscutti G; A Rabiner E; Plisson C
Neurosci Lett; 2019 Jan; 691():11-17. PubMed ID: 30099081
[TBL] [Abstract][Full Text] [Related]
39. Design, Synthesis, and Evaluation of Fluorinated Radioligands for Myelin Imaging.
Tiwari AD; Wu C; Zhu J; Zhang S; Zhu J; Wang WR; Zhang J; Tatsuoka C; Matthews PM; Miller RH; Wang Y
J Med Chem; 2016 Apr; 59(8):3705-18. PubMed ID: 27070324
[TBL] [Abstract][Full Text] [Related]
40. Age-Related Change in 5-HT
Radhakrishnan R; Nabulsi N; Gaiser E; Gallezot JD; Henry S; Planeta B; Lin SF; Ropchan J; Williams W; Morris E; D'Souza DC; Huang Y; Carson RE; Matuskey D
J Nucl Med; 2018 Sep; 59(9):1445-1450. PubMed ID: 29626125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
